Sustained Improvements with Bimekizumab in Spinal Mobility, Physical Function and Health-Related Quality of Life in Patients with Axial Spondyloarthritis: 2-Year Results from Two Phase 3 Studies

被引：0
|
作者：
Navarro Compan, Victoria [1 ]
Dubreuil, Maureen [2 ]
Gaffney, Karl [3 ]
Kay, Jonathan [4 ,5 ]
de la Loge, Christine [6 ]
Massow, Ute [7 ]
Taieb, Vanessa [8 ]
Vaux, Thomas [9 ]
Deodhar, Atul [10 ]
机构：
[1] La Paz Univ Hosp, Hosp La Paz Inst Hlth Res IdiPAZ, Madrid, Spain
[2] Boston Univ, Sch Med, Sect Rheumatol, Boston, MA 02118 USA
[3] Hlth Care NHS, Norwich, Norfolk, England
[4] UMass Chan Med Sch, Div Rheumatol, Dept Med, Worcester, MA USA
[5] UMass Mem Med Ctr, Worcester, MA USA
[6] UCB Pharma, Brussels, Belgium
[7] UCB Pharma, Monheim, Germany
[8] UCB Pharma, Colombes, France
[9] UCB Pharma, Slough, Berks, England
[10] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1480
引用
收藏
页码：3015 / 3018
页数：4
相关论文
共 50 条
  • [11] Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Improvements in Pain and Fatigue: Up to 2-Year Results from Two Phase 3 Studies
    Mease, Philip
    Tillett, William
    de Wit, Maarten
    Gossec, Laure
    Husni, M. Elaine
    Proft, Fabian
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Lambert, Jeremy
    Coates, Laura
    Gottlieb, Alice
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4789 - 4792
  • [12] BIMEKIZUMAB IS ASSOCIATED WITH IMPROVEMENT IN QUALITY OF LIFE IN PATIENTS ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS AT WEEK 16: RESULTS FROM TWO PHASE 3 STUDIES
    McKay, Neil
    Bennett, Alexander
    Goodson, Nicola
    Fleurinck, Carmen
    de la Loge, Christine
    Massow, Ute
    Taieb, Vanessa
    Marzo-Ortega, Helena
    Gaffney, Karl
    RHEUMATOLOGY, 2023, 62
  • [13] IMPACT OF PREGNANCY ON PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN WOMEN WITH AXIAL SPONDYLOARTHRITIS
    Ursin, K.
    Lydersen, S.
    Skomsvoll, J.
    Wallenius, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 529 - 530
  • [14] BIMEKIZUMAB DELIVERED SUSTAINED IMPROVEMENTS IN EFFICACY AND DEMONSTRATED A CONSISTENT SAFETY PROFILE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: UP TO 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Mease, P. J.
    Merola, J. F.
    Landewe, R.
    McInnes, I. B.
    Ritchlin, C. T.
    Tanaka, Y.
    Asahina, A.
    Gossec, L.
    Ink, B.
    Heinrichs, A.
    Bajracharya, R.
    Shende, V
    Coarse, J.
    Coates, L. C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 98 - 99
  • [15] Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
    Mease, Philip J.
    Merola, Joseph F.
    Tanaka, Yoshiya
    Gossec, Laure
    Mcinnes, Iain B.
    Ritchlin, Christopher T.
    Landewe, Robert B. M.
    Asahina, Akihiko
    Ink, Barbara
    Heinrichs, Andrea
    Bajracharya, Rajan
    Shende, Vishvesh
    Coarse, Jason
    Coates, Laura C.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1363 - 1382
  • [16] SUSTAINED IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE FOLLOWING REPEAT ONABOTULINUMTOXINA DETRUSOR INJECTIONS IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY: RESULTS FROM TWO PHASE 3 STUDIES
    Chartier-Kastler, E.
    Rovner, E.
    Chancellor, M.
    Corbell, C.
    Jin, J.
    Globe, D.
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (06) : 763 - 764
  • [17] Bimekizumab Achieved Sustained Improvements in Efficacy Outcomes in Patients with Axial Spondyloarthritis, Regardless of Prior TNF Inhibitor Treatment: Week 52 Pooled Results from Two Phase 3 Studies
    Magrey, Marina Nighat
    van de Sande, Marleen
    Breban, Maxime
    Van den Bosch, Filip
    Fleurinck, Carmen
    Massow, Ute
    De Peyrecave, Natasha
    Vaux, Thomas
    Baraliakos, Xenofon
    Marzo-Ortega, Helena
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1030 - 1032
  • [18] BIMEKIZUMAB ACHIEVED SUSTAINED IMPROVEMENTS IN EFFICACY OUTCOMES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, REGARDLESS OF PRIOR TNF INHIBITOR TREATMENT: WEEK 52 POOLED RESULTS FROM TWO PHASE 3 STUDIES
    Magrey, M.
    Van de Sande, M. G. H.
    Breban, M.
    Van den Bosch, F.
    Fleurinck, C.
    Massow, U.
    De Peyrecave, N.
    Vaux, T.
    Baraliakos, X.
    Marzo-Ortega, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 876 - 877
  • [19] Sustained Improvement in Physical Function, Disease Impact and Health-Related Quality of Life in Patients with Psoriatic Arthritis Treated with Bimekizumab: 3-Year Results from a Phase 2b Open-Label Extension Study
    Gossec, Laure
    Asahina, Akihiko
    Gottlieb, Alice
    Coates, Laura
    Ink, Barbara
    Assudani, Deepak
    Coarse, Jason
    Hellot, Scarlett
    Eells, Jason
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2814 - 2818
  • [20] Sustained Improvement in Physical Function, Health-Related Quality of Life, and Work Productivity with Adalimumab Treatment in NonRadiographic Axial Spondyloarthritis.
    van der Heijde, Desiree
    Mittal, Manish
    Chen, Naijun
    Pangan, Aileen L.
    Joshi, Avani D.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S242 - S242
12345